Dominique Costagliola
Inserm U720
5
0
3
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+2 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Jacques Gasnault, MD
Hopital Bicetre Kremlin Bicetre France
Shared therapeutic areas:
Worked with same sponsors:
Marc Antoine Valantin, MD
Service des Maladies Infectieuses Hopital Pitie-Salpetriere Paris
Shared therapeutic areas:
Worked with same sponsors:
Sylvie Rozenberg, MD
Hopital Pitie-Salpetriere Paris service de Rhumatologie
Shared therapeutic areas:
Worked with same sponsors:
Odile Launay, MD
Hopital Avicenne,Bobigny, Service de Médecine Interne
Shared therapeutic areas:
Worked with same sponsors:
Christophe Piketti, MD
Hopital Georges Pompidou Paris France
Shared therapeutic areas:
Worked with same sponsors:
François Raffi, PHD
Hopital Hotel Dieu Nantes
Shared therapeutic areas:
Worked with same sponsors:
Gilles Pichancourt
CH Henri Duffaut Avignon
Shared therapeutic areas:
Worked with same sponsors:
Bruno Marchou, PHD
CHU Purpan (Toulouse)
Shared therapeutic areas:
Worked with same sponsors:
Jean Luc Schmit
Hôpital Nord Amiens
Shared therapeutic areas:
Worked with same sponsors:
André Cabié
CHU Fort de France
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
Long-Term Supervised Treatment Interruption in HIV-Infected Patients
Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy (ANRS125)
Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated Osteoporosis (ANRS120)
Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance
Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy
All 5 trials loaded